Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 20, 2020

SELL
$34.44 - $43.75 $34,440 - $43,750
-1,000 Closed
0 $0
Q2 2020

Jul 14, 2020

BUY
$27.12 - $45.97 $27,120 - $45,970
1,000 New
1,000 $61,000
Q1 2019

Apr 18, 2019

SELL
$64.44 - $104.11 $45,108 - $72,877
-700 Closed
0 $0
Q4 2018

Jan 29, 2019

SELL
$59.1 - $93.26 $26,831 - $42,340
-454 Reduced 39.34%
700 $69,000
Q3 2018

Oct 29, 2018

BUY
$88.86 - $117.49 $88,593 - $117,137
997 Added 635.03%
1,154 $167,000
Q1 2018

Apr 30, 2018

BUY
$105.8 - $150.94 $16,610 - $23,697
157 New
157 $27,000

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $598M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Harel Insurance Investments & Financial Services Ltd. Portfolio

Follow Harel Insurance Investments & Financial Services Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.